(Q44523504)

3 December 2017

title

Effects of folic acid supplementation on inflammatory and thrombogenic markers in chronic smokers. A randomised controlled trial (English)

1 reference

3 December 2017

1 reference

2

1 reference

3 December 2017

Arduino A Mangoni

1

1 reference

ORCID Public Data File 2021

author name string

Elizabeth Ford

3

1 reference

3 December 2017

Belinda Asonganyi

4

1 reference

3 December 2017

Roy A Sherwood

5

1 reference

3 December 2017

Emma Ouldred

6

1 reference

3 December 2017

Cameron G Swift

7

1 reference

3 December 2017

Stephen H D Jackson

8

1 reference

3 December 2017

publication date

1 April 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

110

1 reference

3 December 2017

issue

1

1 reference

3 December 2017

page(s)

13-17

1 reference

Lifestyle factors and plasma homocysteine concentrations in a general population sample

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900295-0

7 January 2021

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900295-0

7 January 2021

C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900295-0

7 January 2021

Carotid and femoral atherosclerosis, cardiovascular risk factors and C-reactive protein in relation to smokeless tobacco use or smoking in 58-year-old men.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900295-0

7 January 2021

Smoking, other risk factors and fibrinogen levels. evidence of effect modification

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900295-0

7 January 2021

Lifestyle and hemostatic risk factors for ischemic heart disease : the Caerphilly Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900295-0

7 January 2021

Smoking, nicotine and thrombotic risk--a role for platelet dependent thrombin generation?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900295-0

7 January 2021

Associations between homocysteine and coagulation factors--a cross-sectional study in two populations of central Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900295-0

7 January 2021

Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900295-0

7 January 2021

Homocysteine and hemostasis: pathogenic mechanisms predisposing to thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900295-0

7 January 2021

Homocysteine and cardiovascular disease: current evidence and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900295-0

7 January 2021

Enhancement by homocysteine of plasminogen activator inhibitor-1 gene expression and secretion from vascular endothelial and smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900295-0

7 January 2021

Homocystine solubility and vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900295-0

7 January 2021

No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900295-0

7 January 2021

Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900295-0

7 January 2021

The effects of folate supplementation on some coagulation parameters and oxidative status surrogates.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900295-0

7 January 2021

Effects of endothelin on hemodynamics, prostaglandins, blood coagulation and renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900295-0

7 January 2021

Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900295-0

7 January 2021

5-Methyltetrahydrofolate, the Active Form of Folic Acid, Restores Endothelial Function in Familial Hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900295-0

7 January 2021

Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900295-0

7 January 2021

Pro-thrombotic effects of a folic acid deficient diet in rat platelets and macrophages related to elevated homocysteine and decreased n-3 polyunsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900295-0

7 January 2021

Origin of superoxide production by endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900295-0

7 January 2021

Folic Acid Reverts Dysfunction of Endothelial Nitric Oxide Synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900295-0

7 January 2021

10.1016/S0049-3848(03)00295-0

Identifiers

DOI

1 reference

3 December 2017

1 reference